First personalised cancer vaccine cuts risk of disease returning in major trial - BBC

First personalised cancer vaccine cuts risk of disease returning in major trial – BBC

October 23, 2026

First personalised cancer vaccine cuts risk of disease returning in major trial BBC‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows The GuardianMerck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall ReutersModerna shares plunge after cancer vaccine data leaks — despite positive results CNBCModerna’s Stock Plummets After Cancer-Vaccine Data Shared on Social Media WSJ